Sign up for free insights newsletter
EQ

Equasens S. A.

EQSEuronext Paris

Need professional-grade analysis? Visit stockanalysis.com

€33.90
-3.00%
End of day
Market Cap

$531.36M

P/E Ratio

14.79

Employees

1,400

Dividend Yield

3.49%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-2.39-1.730.07-0.69-1.01
Calmar-2.42-1.630.04-0.25-0.87
Sharpe-1.89-1.260.04-0.51-0.77
Omega0.560.741.040.930.86
Martin-3.84-3.000.09-0.42-1.48
Ulcer15.3114.1018.4739.2523.00

Equasens S. A. (EQS) Price Performance

Equasens S. A. (EQS) trades on Euronext Paris in EUR. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at EUR33.90, down 3.00% from the previous close.

Over the past year, EQS has traded between a low of EUR31.82 and a high of EUR53.50. The stock has lost 3.1% over this period. It is currently 36.6% below its 52-week high.

Equasens S. A. has a market capitalization of $531.36M, with a price-to-earnings ratio of 14.79 and a dividend yield of 3.49%.

About Equasens S. A.

Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare professionals and other tertiary sectors. It serves healthcare facilities and private healthcare professionals. The company was incorporated in 1996 and is headquartered in Villers-les-Nancy, France. Equasens Société anonyme operates as a subsidiary of Marque Verte Sante.

Company Info

Exchange
Euronext Paris
Currency
EUR
Country
France

Financial Metrics

Revenue (TTM)
$224.73M
EBITDA
$43.42M
Profit Margin
16.16%
EPS (TTM)
2.39
Book Value
15.30

Technical Indicators

52 Week High
€53.70
52 Week Low
€29.77
50 Day MA
€40.16
200 Day MA
€44.17
Beta
0.86

Valuation

Trailing P/E
14.79
Forward P/E
N/A
Price/Sales
2.36
Price/Book
2.30
Enterprise Value
$539.84M